person · Reporting owner
VanHimbergen Robert M
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Elanco Animal Health IncELAN · Entity 3457 | EVP and CFO | October 02, 2026 | October 06, 2026 |
| Hillenbrand, Inc.HI · Entity 66702 | Sr. VP, CFO | March 31, 2025 | April 02, 2025 |
| Johnson Controls International plcJCI · Entity 2940 | VP Corporate Controller | February 25, 2022 | February 28, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Elanco Animal Health Inc
Report date October 02, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 167.5523 |
Reported balance
After 2026-10-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-02 · Grant · Acquired 8.8988 · Balance 167.5523 F1: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
F2: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Hillenbrand, Inc.
Report date March 31, 2025 · Filed April 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 71,793 |
Ending reported balance
After 2025-03-31 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-03-31 · Exercise / conversion · Acquired 212 · Balance 71,893 F1: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. Row 2 · 2025-03-31 · Tax withholding · Disposed 100 · Balance 71,793 |
| Restricted Stock Units (Deferred Stock Award 12/07/2022)SEC Table II · derivative / convertible security | Direct | 2,828 |
Reported balance
After 2025-03-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-03-31 · Grant · Acquired 26 · Balance 2,828 F1: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. F2: Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates. F3: Restricted Stock Units scheduled to vest one-third on 12/7/2023, one-third on 12/7/2024, and one-third on 12/7/2025. |
| Restricted Stock Units (Deferred Stock Award 12/7/2023)SEC Table II · derivative / convertible security | Direct | 7,942 |
Reported balance
After 2025-03-31 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-03-31 · Grant · Acquired 73 · Balance 7,942 F1: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. F2: Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates. F4: Restricted Stock Units scheduled to vest one-third on 12/7/2024, one-third on 12/7/2025, and one-third on 12/7/2026. |
| Restricted Stock Units (Deferred Stock Award 12/5/2024)SEC Table II · derivative / convertible security | Direct | 14,759 |
Reported balance
After 2025-03-31 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-03-31 · Grant · Acquired 136 · Balance 14,759 F1: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. F2: Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates. F5: Restricted Stock Units scheduled to vest one-third on 12/5/2025, one-third on 12/5/2026, and one-third on 12/5/2027. |
| Restricted Stock Units (Matching RSU Framework 03/31/2025)SEC Table II · derivative / convertible security | Direct | 20,239 |
Reported balance
After 2025-03-31 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-03-31 · Grant · Acquired 20,239 · Balance 20,239 F1: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. F2: Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates. F6: Represents Matching RSUs granted under the Company's Executive Share Match framework that will vest on March 31, 2028 and be settled in shares of the Company's common stock or cash to the extent the vesting conditions of the framework are satisfied. |
| Restricted Stock Units (Deferred Stock Award 3/14/2022)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-03-31 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2025-03-31 · Exercise / conversion · Disposed 212 · Balance 0 F1: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. F2: Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates. F7: Restricted Stock Units scheduled to vest one-third on 3/14/2023, one-third on 3/14/2024, and one-third on 3/14/2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock.
F2: Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates.
F3: Restricted Stock Units scheduled to vest one-third on 12/7/2023, one-third on 12/7/2024, and one-third on 12/7/2025.
F4: Restricted Stock Units scheduled to vest one-third on 12/7/2024, one-third on 12/7/2025, and one-third on 12/7/2026.
F5: Restricted Stock Units scheduled to vest one-third on 12/5/2025, one-third on 12/5/2026, and one-third on 12/5/2027.
F6: Represents Matching RSUs granted under the Company's Executive Share Match framework that will vest on March 31, 2028 and be settled in shares of the Company's common stock or cash to the extent the vesting conditions of the framework are satisfied.
F7: Restricted Stock Units scheduled to vest one-third on 3/14/2023, one-third on 3/14/2024, and one-third on 3/14/2025.
Johnson Controls International plc
Report date February 25, 2022 · Filed February 28, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 39,617.58 |
Ending reported balance
After 2022-02-25 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-02-25 · Exercise / conversion · Acquired 5,683 · Balance 45,300.58 F1: Transaction effected pursuant to a Rule 10b5-1 trading plan. Row 2 · 2022-02-25 · Sale · Disposed 5,683 · Balance 39,617.58 F1: Transaction effected pursuant to a Rule 10b5-1 trading plan. F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.32 to $64.61 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 of this Form 4. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.39 · Expires 2028-12-06 | Direct | 15,000 |
Reported balance
After 2022-02-25 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-02-25 · Exercise / conversion · Disposed 5,683 · Balance 15,000 F1: Transaction effected pursuant to a Rule 10b5-1 trading plan. |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy 401k Plan Trustee | 6,758.59 |
Reported balance
Holding disclosure · report date 2022-02-25 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 6,758.59 |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction effected pursuant to a Rule 10b5-1 trading plan.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.32 to $64.61 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 of this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2026 Filed Oct 6, 2026 20:35 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 8.8988 | $22.14 | $197.02 |
DisclosureSEC source: 0001724169-26-000045 · form4-10062026_081047.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167.5523 Underlying: Common Stock · 8.8988 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 20:04 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 8.7877 | $22.42 | $197.02 |
DisclosureSEC source: 0001724169-26-000043 · form4-09222026_080956.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158.6535 Underlying: Common Stock · 8.7877 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 21:10 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 8.0416 | $24.50 | $197.02 |
DisclosureSEC source: 0001724169-26-000041 · form4-09092026_090937.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149.8658 Underlying: Common Stock · 8.0416 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 20:42 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 8.2194 | $23.97 | $197.02 |
DisclosureSEC source: 0001724169-26-000039 · form4-08252026_080858.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141.8242 Underlying: Common Stock · 8.2194 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| August 07, 2026 Filed Aug 10, 2026 20:14 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 8.9069 | $22.12 | $197.02 |
DisclosureSEC source: 0001724169-26-000037 · form4-08102026_080855.xml · derivative · entry 2 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133.6048 Underlying: Common Stock · 8.9069 shares Expires not disclosed F2 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F3 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F3 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| August 07, 2026 Filed Aug 10, 2026 20:14 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 4,200 | $23.08 | $96,925.92 |
DisclosureSEC source: 0001724169-26-000037 · form4-08102026_080855.xml · nonDerivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,516 F1 · price: Reflects the weighted average price of 4,200 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on August 7, 2026 with purchase prices ranging from $23.01 to $23.09 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| July 24, 2026 Filed Jul 28, 2026 21:34 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 7.9093 | $24.91 | $197.02 |
DisclosureSEC source: 0001724169-26-000035 · form4-07282026_090707.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124.6979 Underlying: Common Stock · 7.9093 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| July 10, 2026 Filed Jul 14, 2026 20:15 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 7.938 | $24.82 | $197.02 |
DisclosureSEC source: 0001724169-26-000033 · form4-07142026_080706.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116.7886 Underlying: Common Stock · 7.938 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 20:19 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 15,336 | $24.64 | $377,879.04 |
DisclosureSEC source: 0001724169-26-000031 · form4-07092026_080755.xml · nonDerivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,316 Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 20:28 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 8.0187 | $24.57 | $197.02 |
DisclosureSEC source: 0001724169-26-000029 · form4-06302026_080610.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108.8506 Underlying: Common Stock · 8.0187 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 20:33 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 8.1514 | $24.17 | $197.02 |
DisclosureSEC source: 0001724169-26-000027 · form4-06162026_080650.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100.8319 Underlying: Common Stock · 8.1514 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 21:12 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 8.2608 | $23.85 | $197.02 |
DisclosureSEC source: 0001724169-26-000025 · form4-06022026_090657.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92.6805 Underlying: Common Stock · 8.2608 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:37 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 9.9204 | $19.86 | $197.02 |
DisclosureSEC source: 0001724169-26-000023 · form4-05192026_080552.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84.4197 Underlying: Common Stock · 9.9204 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:11 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 8.7526 | $22.51 | $197.02 |
DisclosureSEC source: 0001724169-26-000021 · form4-05052026_080535.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74.4993 Underlying: Common Stock · 8.7526 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| April 17, 2026 Filed Apr 21, 2026 20:30 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 8.3201 | $23.68 | $197.02 |
DisclosureSEC source: 0001724169-26-000019 · form4-04212026_080454.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65.7467 Underlying: Common Stock · 8.3201 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| April 03, 2026 Filed Apr 7, 2026 21:18 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 8.6337 | $22.82 | $197.02 |
DisclosureSEC source: 0001724169-26-000017 · form4-04072026_090414.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57.4266 Underlying: Common Stock · 8.6337 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 20:31 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 8.216 | $23.98 | $197.02 |
DisclosureSEC source: 0001724169-26-000015 · form4-03242026_080344.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48.7929 Underlying: Common Stock · 8.216 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:14 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 9.485 | $23.36 | $221.57 |
DisclosureSEC source: 0001724169-26-000012 · form4-03102026_080341.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40.5769 Underlying: Common Stock · 9.485 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:15 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantEmployee Stock Option (right to buy) · Derivative | 48,375 | $0.00 Strike: $26.40 | $0.00 |
DisclosureSEC source: 0001724169-26-000010 · form4-03042026_120351.xml · derivative · entry 2 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,375 Underlying: Common Stock · 48,375 shares Expires 2036-03-01 F3 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 4, 2026 00:15 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 23,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001724169-26-000010 · form4-03042026_120351.xml · nonDerivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,652 F1 · shares: Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. F2 · balance_after: Includes 744 shares acquired under Elanco Animal Health Inc.'s Employee Stock Purchase Plan on January 31, 2026. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 21:43 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 7.6217 | $24.98 | $190.39 |
DisclosureSEC source: 0001724169-26-000008 · form4-02242026_090213.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31.0919 Underlying: Common Stock · 7.6217 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:33 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 7.5552 | $25.20 | $190.39 |
DisclosureSEC source: 0001724169-26-000006 · form4-02102026_090227.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23.4702 Underlying: Common Stock · 7.5552 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:27 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 7.8029 | $24.40 | $190.39 |
DisclosureSEC source: 0001724169-26-000004 · form4-01272026_090118.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15.915 Underlying: Common Stock · 7.8029 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 23:10 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 8.1121 | $23.47 | $190.39 |
DisclosureSEC source: 0001724169-26-000002 · form4-01132026_110106.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.1121 Underlying: Common Stock · 8.1121 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 21:42 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 6,950 | $21.64 | $150,426.50 |
DisclosureSEC source: 0001724169-25-000007 · form4-12152025_091224.xml · nonDerivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,233 F1 · price: Reflects the weighted average price of 6,950 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on December 11, 2025 with purchase prices ranging from $21.60 to $21.70 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. F2 · balance_after: The balance includes 7,426 shares that were previously reported but inadvertently omitted from the reporting person's balance on his last Form 4. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 21:10 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantEmployee Stock Option (right to buy) · Derivative | 53,869 | $0.00 Strike: $20.80 | $0.00 |
DisclosureSEC source: 0001724169-25-000005 · form4-10032025_091033.xml · derivative · entry 2 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,869 Underlying: Common Stock · 53,869 shares Expires 2035-10-01 F2 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on July 7, 2026, one-third vesting on July 7, 2027, and the remaining vesting on July 7, 2028. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 21:10 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 109,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001724169-25-000005 · form4-10032025_091033.xml · nonDerivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,857 F1 · shares: Grant of restricted stock units vesting as follows: one-third vesting on July 7, 2026, one-third vesting on July 7, 2027, and the remaining vesting on July 7, 2028. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:25 UTC | Hillenbrand, Inc. HI · Entity 66702 | Exercise / conversionRestricted Stock Units (Deferred Stock Award 3/14/2022) · Derivative | 212 | $0.00 | $0.00 |
DisclosureSEC source: 0001417398-25-000147 · wk-form4_1743625511.xml · derivative · entry 7 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 212 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. F2 · kind: Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates. F7 · derivative.exercise_date: Restricted Stock Units scheduled to vest one-third on 3/14/2023, one-third on 3/14/2024, and one-third on 3/14/2025. F7 · derivative.expiration_date: Restricted Stock Units scheduled to vest one-third on 3/14/2023, one-third on 3/14/2024, and one-third on 3/14/2025. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:25 UTC | Hillenbrand, Inc. HI · Entity 66702 | GrantRestricted Stock Units (Matching RSU Framework 03/31/2025) · Derivative | 20,239 | $0.00 | $0.00 |
DisclosureSEC source: 0001417398-25-000147 · wk-form4_1743625511.xml · derivative · entry 6 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,239 Underlying: Common Stock · 20,239 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. F2 · kind: Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates. F6 · derivative.exercise_date: Represents Matching RSUs granted under the Company's Executive Share Match framework that will vest on March 31, 2028 and be settled in shares of the Company's common stock or cash to the extent the vesting conditions of the framework are satisfied. F6 · derivative.expiration_date: Represents Matching RSUs granted under the Company's Executive Share Match framework that will vest on March 31, 2028 and be settled in shares of the Company's common stock or cash to the extent the vesting conditions of the framework are satisfied. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:25 UTC | Hillenbrand, Inc. HI · Entity 66702 | GrantRestricted Stock Units (Deferred Stock Award 12/5/2024) · Derivative | 136 | $0.00 | $0.00 |
DisclosureSEC source: 0001417398-25-000147 · wk-form4_1743625511.xml · derivative · entry 5 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,759 Underlying: Common Stock · 136 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. F2 · kind: Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates. F5 · derivative.exercise_date: Restricted Stock Units scheduled to vest one-third on 12/5/2025, one-third on 12/5/2026, and one-third on 12/5/2027. F5 · derivative.expiration_date: Restricted Stock Units scheduled to vest one-third on 12/5/2025, one-third on 12/5/2026, and one-third on 12/5/2027. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:25 UTC | Hillenbrand, Inc. HI · Entity 66702 | GrantRestricted Stock Units (Deferred Stock Award 12/7/2023) · Derivative | 73 | $0.00 | $0.00 |
DisclosureSEC source: 0001417398-25-000147 · wk-form4_1743625511.xml · derivative · entry 4 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,942 Underlying: Common Stock · 73 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. F2 · kind: Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates. F4 · derivative.exercise_date: Restricted Stock Units scheduled to vest one-third on 12/7/2024, one-third on 12/7/2025, and one-third on 12/7/2026. F4 · derivative.expiration_date: Restricted Stock Units scheduled to vest one-third on 12/7/2024, one-third on 12/7/2025, and one-third on 12/7/2026. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:25 UTC | Hillenbrand, Inc. HI · Entity 66702 | GrantRestricted Stock Units (Deferred Stock Award 12/07/2022) · Derivative | 26 | $0.00 | $0.00 |
DisclosureSEC source: 0001417398-25-000147 · wk-form4_1743625511.xml · derivative · entry 3 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,828 Underlying: Common Stock · 26 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. F2 · kind: Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates. F3 · derivative.exercise_date: Restricted Stock Units scheduled to vest one-third on 12/7/2023, one-third on 12/7/2024, and one-third on 12/7/2025. F3 · derivative.expiration_date: Restricted Stock Units scheduled to vest one-third on 12/7/2023, one-third on 12/7/2024, and one-third on 12/7/2025. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:25 UTC | Hillenbrand, Inc. HI · Entity 66702 | Tax withholdingCommon Stock | 100 | $24.13 | $2,413.20 |
DisclosureSEC source: 0001417398-25-000147 · wk-form4_1743625511.xml · nonDerivative · entry 2 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,793 Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:25 UTC | Hillenbrand, Inc. HI · Entity 66702 | Exercise / conversionCommon Stock | 212 | $0.00 | $0.00 |
DisclosureSEC source: 0001417398-25-000147 · wk-form4_1743625511.xml · nonDerivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 20:07 UTC | Hillenbrand, Inc. HI · Entity 66702 | Exercise / conversionRestricted Stock Units (Deferred Stock Award 3/14/2022) · Derivative | 22,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001417398-25-000102 · wk-form4_1742328444.xml · derivative · entry 3 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,757 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: Restricted Stock Units scheduled to vest one-third on 3/14/2023, one-third on 3/14/2024, and one-third on 3/14/2025. F2 · derivative.expiration_date: Restricted Stock Units scheduled to vest one-third on 3/14/2023, one-third on 3/14/2024, and one-third on 3/14/2025. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 20:07 UTC | Hillenbrand, Inc. HI · Entity 66702 | Tax withholdingCommon Stock | 10,671 | $25.00 | $266,775.00 |
DisclosureSEC source: 0001417398-25-000102 · wk-form4_1742328444.xml · nonDerivative · entry 2 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,681 Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 20:07 UTC | Hillenbrand, Inc. HI · Entity 66702 | Exercise / conversionCommon Stock | 22,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001417398-25-000102 · wk-form4_1742328444.xml · nonDerivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| February 10, 2025 Filed Feb 10, 2025 21:10 UTC | Hillenbrand, Inc. HI · Entity 66702 | PurchaseCommon Stock | 2,000 | $32.85 | $65,698.00 |
DisclosureSEC source: 0001417398-25-000068 · wk-form4_1739221835.xml · nonDerivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,595 Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:11 UTC | Hillenbrand, Inc. HI · Entity 66702 | GrantRestricted Stock Units (Deferred Stock Award 12/5/2024) · Derivative | 106 | $0.00 | $0.00 |
DisclosureSEC source: 0001417398-25-000036 · wk-form4_1735938675.xml · derivative · entry 4 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,623 Underlying: Common Stock · 106 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. F2 · kind: Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates. F6 · derivative.exercise_date: Restricted Stock Units scheduled to vest one-third on 12/5/2025, one-third on 12/5/2026, and one-third on 12/5/2027. F6 · derivative.expiration_date: Restricted Stock Units scheduled to vest one-third on 12/5/2025, one-third on 12/5/2026, and one-third on 12/5/2027. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:11 UTC | Hillenbrand, Inc. HI · Entity 66702 | GrantRestricted Stock Units (Deferred Stock Award 12/7/2023) · Derivative | 57 | $0.00 | $0.00 |
DisclosureSEC source: 0001417398-25-000036 · wk-form4_1735938675.xml · derivative · entry 3 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,869 Underlying: Common Stock · 57 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. F2 · kind: Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates. F5 · derivative.exercise_date: Restricted Stock Units scheduled to vest one-third on 12/7/2024, one-third on 12/7/2025, and one-third on 12/7/2026. F5 · derivative.expiration_date: Restricted Stock Units scheduled to vest one-third on 12/7/2024, one-third on 12/7/2025, and one-third on 12/7/2026. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:11 UTC | Hillenbrand, Inc. HI · Entity 66702 | GrantRestricted Stock Units (Deferred Stock Award 12/07/2022) · Derivative | 20 | $0.00 | $0.00 |
DisclosureSEC source: 0001417398-25-000036 · wk-form4_1735938675.xml · derivative · entry 2 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,802 Underlying: Common Stock · 20 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. F2 · kind: Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates. F4 · derivative.exercise_date: Restricted Stock Units scheduled to vest one-third on 12/7/2023, one-third on 12/7/2024, and one-third on 12/7/2025. F4 · derivative.expiration_date: Restricted Stock Units scheduled to vest one-third on 12/7/2023, one-third on 12/7/2024, and one-third on 12/7/2025. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:11 UTC | Hillenbrand, Inc. HI · Entity 66702 | GrantRestricted Stock Units (Deferred Stock Award 3/14/2022) · Derivative | 165 | $0.00 | $0.00 |
DisclosureSEC source: 0001417398-25-000036 · wk-form4_1735938675.xml · derivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,757 Underlying: Common Stock · 165 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. F2 · kind: Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates. F3 · derivative.exercise_date: Restricted Stock Units scheduled to vest one-third on 3/14/2023, one-third on 3/14/2024, and one-third on 3/14/2025. F3 · derivative.expiration_date: Restricted Stock Units scheduled to vest one-third on 3/14/2023, one-third on 3/14/2024, and one-third on 3/14/2025. Read SEC document |
| December 07, 2024 Filed Dec 10, 2024 21:13 UTC | Hillenbrand, Inc. HI · Entity 66702 | Exercise / conversionRestricted Stock Units (Deferred Stock Award 12/7/2023) · Derivative | 3,904 | $0.00 | $0.00 |
DisclosureSEC source: 0001417398-24-000310 · wk-form4_1733865222.xml · derivative · entry 4 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,812 Underlying: Common Stock · 3,904 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. F2 · kind: Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates. F4 · derivative.exercise_date: Restricted Stock Units scheduled to vest one-third on 12/7/2024, one-third on 12/7/2025, and one-third on 12/7/2026. F4 · derivative.expiration_date: Restricted Stock Units scheduled to vest one-third on 12/7/2024, one-third on 12/7/2025, and one-third on 12/7/2026. Read SEC document |
| December 07, 2024 Filed Dec 10, 2024 21:13 UTC | Hillenbrand, Inc. HI · Entity 66702 | Exercise / conversionRestricted Stock Units (Deferred Stock Award 12/07/2022) · Derivative | 2,784 | $0.00 | $0.00 |
DisclosureSEC source: 0001417398-24-000310 · wk-form4_1733865222.xml · derivative · entry 3 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,782 Underlying: Common Stock · 2,784 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. F2 · kind: Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates. F3 · derivative.exercise_date: Restricted Stock Units scheduled to vest one-third on 12/7/2023, one-third on 12/7/2024, and one-third on 12/7/2025. F3 · derivative.expiration_date: Restricted Stock Units scheduled to vest one-third on 12/7/2023, one-third on 12/7/2024, and one-third on 12/7/2025. Read SEC document |
| December 07, 2024 Filed Dec 10, 2024 21:13 UTC | Hillenbrand, Inc. HI · Entity 66702 | Tax withholdingCommon Stock | 3,144 | $33.10 | $104,066.40 |
DisclosureSEC source: 0001417398-24-000310 · wk-form4_1733865222.xml · nonDerivative · entry 2 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,595 Read SEC document |
| December 07, 2024 Filed Dec 10, 2024 21:13 UTC | Hillenbrand, Inc. HI · Entity 66702 | Exercise / conversionCommon Stock | 6,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001417398-24-000310 · wk-form4_1733865222.xml · nonDerivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| December 05, 2024 Filed Dec 6, 2024 21:10 UTC | Hillenbrand, Inc. HI · Entity 66702 | GrantRestricted Stock Units (Deferred Stock Award 12/5/2024) · Derivative | 14,517 | $0.00 | $0.00 |
DisclosureSEC source: 0001417398-24-000290 · wk-form4_1733519409.xml · derivative · entry 3 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,517 Underlying: Common Stock · 14,517 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock. F3 · kind: Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates. F4 · derivative.exercise_date: Restricted Stock Units scheduled to vest one-third on 12/5/2025, one-third on 12/5/2026, and one-third on 12/5/2027. F4 · derivative.expiration_date: Restricted Stock Units scheduled to vest one-third on 12/5/2025, one-third on 12/5/2026, and one-third on 12/5/2027. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:10 UTC | Hillenbrand, Inc. HI · Entity 66702 | Tax withholdingCommon Stock | 3,304 | $34.27 | $113,228.08 |
DisclosureSEC source: 0001417398-24-000290 · wk-form4_1733519409.xml · nonDerivative · entry 2 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,051 Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:10 UTC | Hillenbrand, Inc. HI · Entity 66702 | Exercise / conversionCommon Stock | 7,029 | $34.27 | $240,883.83 |
DisclosureSEC source: 0001417398-24-000290 · wk-form4_1733519409.xml · nonDerivative · entry 1 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · acquired: Consists of shares issued upon vesting of performance-based restricted stock units. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 21:07 UTC | Hillenbrand, Inc. HI · Entity 66702 | Exercise / conversionRestricted Stock Units (Deferred Stock Award 3/14/2022) · Derivative | 2,891 | $0.00 | $0.00 |
DisclosureSEC source: 0001417398-24-000269 · wk-form4_1733346438.xml · derivative · entry 3 VanHimbergen Robert M · CIK 0001724169 · Sr. VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,891 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Conversion of Exercise Price of Derivative Securities is 1-for-1. F2 · derivative.exercise_date: Restricted Stock Units scheduled to vest one-third on 12/2/2022, one-third on 12/2/2023, and one-third on 12/2/2024. F2 · derivative.expiration_date: Restricted Stock Units scheduled to vest one-third on 12/2/2022, one-third on 12/2/2023, and one-third on 12/2/2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.